Citations

Clear

9383 citation(s) found for "Thomas, PS".

Pathologic findings in prospectively ascertained essential tremor subjects
Shill, Holly A. , Connor, Donald J., Caviness, John N., Hentz, Joseph G. , Beach, Thomas G. , Adler, Charles H. , Sabbagh, Marwan Noel

Mayo Clinic

Neurology | May 4, 2008 | Volume: 70 | Issue: 16_part_2 | Pages: 1452-1455

10.1212/01.wnl.0000310425.76205.02 | PMID 18413570 Get It

Percutaneous Renal Cryoablation: Experience Treating 115 Tumors
Atwell, Thomas D. , Farrell, Michael A., Leibovich, Bradley C. , Callstrom, Matthew R. , Chow, George K. , Blute, Michael L., Charboneau, J. William

Mayo Clinic

Journal of Urology | April 18, 2008 | Volume: 179 | Issue: 6 | Pages: 2136-2141

10.1016/j.juro.2008.01.144 | PMID 18423719 Get It

Report of the ATSA Task Force on Children With Sexual Behavior Problems
Chaffin, Mark , Berliner, Lucy , Block, Richard, Johnson, Toni Cavanagh, Friedrich, William N., Louis, Diana Garza , Lyon, Thomas D. , Page, I. Jacqueline, Prescott, David S. , Silovsky, Jane F. , Madden, Christi

Mayo Clinic

Child Maltreatment | April 12, 2008 | Volume: 13 | Issue: 2 | Pages: 199-218

10.1177/1077559507306718 | PMID 18408214 Get It

Gene-Modified Mesenchymal Stem Cells Express Functionally Active Nerve Growth Factor on an Engineered Poly Lactic Glycolic Acid (PLGA) Substrate
Rooney, Gemma E., Moran, Cathal J., McMahon, Siobhán S. , Ritter, Thomas , Maenz, Martin, Flügel, Alexander , Dockery, Peter , O’Brien, Timothy , Howard, Linda , Windebank, Anthony J. , Barry, Frank

Mayo Clinic

Tissue Engineering Part A | April 11, 2008 | Volume: 14 | Issue: 5 | Pages: 681-690

10.1089/tea.2007.0260 | PMID 18402551 Get It

Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal Women
Ghosh, Karthik, Brandt, Kathleen R. , Sellers, Thomas A. , Reynolds, Carol, Scott, Christopher G. , Maloney, Shaun D., Carston, Michael J., Vachon, Celine M. , Pankratz, V. Shane , Vachon, Celine M. , Scott, Christopher

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | April 8, 2008 | Volume: 17 | Issue: 4 | Pages: 872-879

10.1158/1055-9965.epi-07-0559 | PMID 18398028 Get It

AbstractBackground: Limited studies have examined the associations between mammographic density and subsequent breast tumor characteristics.Methods: Eligible women were part of a case-control study of postmenopausal breast cancer, were 40 years or older and had a routine mammogram 4 years or more before their diagnosis. Mammographic density (percent density, dense area, and nondense area) was estimated using a computer-assisted thresholding program. At the time of cancer diagnosis, cases were classified as asymptomatic or symptomatic based on medical record review and breast imaging workup. Pathologic review was done blinded to the density status. Linear regression models and tests for trend examined the association between pathologic characteristics of the breast tumor and the components of density for all participants, and stratified by symptom status at diagnosis.Results: Of the 286 eligible cases, 77% were 60 years or older and mean percent density was 29.5% (SD, 14.6%). Density was not significantly associated with tumor size (P = 0.22), histologic type (P = 0.77), estrogen receptor (P = 0.11) or progesterone receptor (P = 0.37) status, mitotic activity (P = 0.12), or nuclear pleomorphism (P = 0.09; P values for percent density). An inverse association was suggested between tumor grade and percent density (32.0%, 30.3%, 26.7% for grades 1-3; P = 0.06 for trend). The inverse association with tumor grade and its components (nuclear pleomorphism and tubular differentiation) was only evident among the 97 symptomatic women; positive associations of estrogen receptor (P = 0.009) and progesterone receptor (P = 0.04) were also seen with percent density only in this subgroup.Conclusions: The inverse association between tumor grade and percent density in the symptomatic population could inform the biology of the association between mammographic density and breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2008;17(4):872–9)
Idiopathic Nonspecific Interstitial Pneumonia
Hunninghake, Gary W., King, Talmadge E. , Lynch, David A. , Colby, Thomas V. , Galvin, Jeffrey R. , Brown, Kevin M. , Chung, Man Pyo , Cordier, Jean-François, Bois, Roland M. du, Flaherty, Kevin R., Franks, Teri J. , Hansell, David M., Hartman, Thomas E. , Kazerooni, Ella A. , Kim, Dong Soon, Kitaichi, Masanori, Koyama, Takashi , Nagai, Sonoko, Midthun, David E. , Müller, Nestor L., Raghu, Ganesh , Selman, Moisés , Wells, Athol U. , Travis, William D. , Flaherty, Kevin R., Martínez, Fernando J. , Nicholson, Andrew G.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 3, 2008 | Volume: 177 | Issue: 12 | Pages: 1338-1347

10.1164/rccm.200611-1685oc | PMID 18388353 Get It

Abstract Rationale The 2002 American Thoracic Society/European Respiratory Society classification of idiopathic interstitial pneumonias identified nonspecific interstitial pneumonia (NSIP) as a provisional diagnosis. Concern was expressed that NSIP was a “wastebasket” category, difficult to distinguish from other idiopathic interstitial pneumonias. Objectives The following questions were addressed: (1) Is idiopathic NSIP a distinct entity? 2) If so, what are its clinical, radiologic and pathologic characteristics? (3) What is the role of radiology and pathology in establishing the diagnosis? (4) To make a diagnosis of idiopathic NSIP, what other disorders need to be excluded and how should this be done? Methods Investigators who had previously reported cases of idiopathic NSIP were invited to submit cases for review (n = 305). After initial review, cases with complete clinical, radiologic, and pathologic information (n = 193) were reviewed in a series of workshops. Measurements and Main Results Sixty-seven cases were identified as NSIP. Mean age was 52 years, 67% were women, 69% were never-smokers, and 46% were from Asian countries. The most common symptoms were dyspnea (96%) and cough (87%); 69% had restriction. By high-resolution computed tomography, the lower lung zones were predominantly involved in 92% of cases; 46% had a peripheral distribution; 47% were diffuse. Most showed a reticular pattern (87%) with traction bronchiectasis (82%) and volume loss (77%). Lung biopsies showed uniform thickening of alveolar walls with a spectrum of cellular to fibrosing patterns. Five-year survival was 82.3%. Conclusions Idiopathic NSIP is a distinct clinical entity that occurs mostly in middle-aged women who are never-smokers. The prognosis of NSIP is very good.
Origins and Prevalence of the American Founder Mutation of MSH2
Baze, Mark E., Walsh, Kyle M. , Liyanarachchi, Sandya , Fix, Dan, Schunemann, Victoria , Comeras, Ilene, Deacon, Molly, Lynch, Jane F., Gong, Gordon, Thomas, Brittany C. , Thibodeau, Stephen N. , Lynch, Henry T., Chapelle, Albert de la , Clendenning, Mark , Sun, Shuying , Hampel, Heather

Mayo Clinic

Cancer Research | April 1, 2008 | Volume: 68 | Issue: 7 | Pages: 2145-2153

10.1158/0008-5472.can-07-6599 | PMID 18381419 Get It

Abstract Large germline deletions within the mismatch repair gene MSH2 account for a significant proportion (up to 20%) of all deleterious mutations of this gene which are associated with Lynch syndrome. An exons 1 to 6 deletion of MSH2, originally reported in nine families, has been associated with a founding event within the United States, which genealogic studies had previously dated to 1727, and the number of present day carriers was estimated to be 18,981. Here, we report the development of a robust multiplex PCR which has assisted in the detection of 32 new families who carry the MSH2 American Founder Mutation (AFM). By offering testing to family members, 126 carriers of the AFM have been identified. Extensive genealogic studies have connected 27 of the 41 AFM families into seven extended pedigrees. These extended families have been traced back to around the 18th century without any evidence of further convergence between them. Characterization of the genomic sequence flanking the deletion and the identification of a common disease haplotype of between 0.6 and 2.3 Mb in all probands provides evidence for a common ancestor between these extended families. The DMLE+2.2 software predicts an age of ∼500 years (95% confidence interval, 425–625) for this mutation. Taken together, these data are suggestive of an earlier founding event than was first thought, which likely occurred in a European or a Native American population. The consequences of this finding would be that the AFM is significantly more frequent in the United States than was previously predicted. [Cancer Res 2008;68(7):2145–53]
Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk
Kelemen, Linda E. , Sellers, Thomas A. , Schildkraut, Joellen M. , Cunningham, Julie M. , Vierkant, Robert A. , Pankratz, V. Shane , Fredericksen, Zachary S., Gadre, Madhura K., Rider, David N., Liebow, Mark , Goode, Ellen L. , Vierkant, Robert A

Mayo Clinic

Cancer Research | April 1, 2008 | Volume: 68 | Issue: 7 | Pages: 2498-2506

10.1158/0008-5472.can-07-5165 | PMID 18381459 Get It

Abstract Dysfunction in enzymes involved in one-carbon (1-C) metabolism can lead to increased chromosomal strand breaking and abnormal methylation patterns, which are both associated with cancer risk. Availability of 1-C units may modify risk. We investigated the association of single-nucleotide polymorphisms (SNP) in 21 genes in the 1-C transfer pathway among 829 Caucasian cases with primary epithelial ovarian cancer and 941 frequency-matched unaffected controls enrolled at Mayo Clinic (Rochester, MN) and Duke University (Durham, NC) and examined risk modification by multivitamin supplement use. Multivariable-adjusted SNP-specific logistic regression and haplotype analyses were done for 180 SNPs and false positive report probabilities (FPRP) were calculated. Each copy of the minor allele in SHMT1 intron 5 A>G (rs9909104) was associated with epithelial ovarian cancer [odds ratio (OR), 1.2; 95% confidence interval (95% CI), 1.0–1.4; P trend = 0.02; FPRP = 0.16] and a 5-SNP SHMT1 haplotype was associated with decreased risk (P = 0.01; FPRP = 0.09). Three SNPs in DNMT3A were associated with risk among multivitamin supplement users: 3′ untranslated region (UTR) C>G (rs13420827: OR, 0.8; 95% CI, 0.6–1.0; P interaction = 0.006; FPRP = 0.54), intron 6 G>A (rs11887120: OR, 0.8; 95% CI, 0.7–1.0; P interaction = 0.007; FPRP = 0.57), and intron 22 A>T (rs11695471: OR, 1.2; 95% CI, 1.0–1.5; P interaction = 0.01; FPRP = 0.66). These data extend previous findings from other cancers of a role for SHMT1 in ovarian cancer, and provide evidence that SNPs in methylation and DNA synthesis reactions are associated with risk of ovarian cancer. Interventions with modifiable factors such as multivitamin intake may reduce risk. [Cancer Res 2008;68(7):2498–506]
Contrasting the Neurologic Complications of Cardiac Transplantation in Adults and Children
Mayer, Thomas O., Biller, José , O’Donnell, Jacqueline, Sokol, Deborah K. , Meschia, James F.

Mayo Clinic

Journal of Child Neurology | March 31, 2008 | Volume: 17 | Issue: 3 | Pages: 195-199

10.1177/088307380201700308 | PMID 12026235 Get It

The objective of this study was to evaluate neurologic complications associated with cardiac transplantation and compare the neurologic complications seen in adults and children. As advances in immunology have led to longer survival times for cardiac transplant recipients (1- and 5-year survival rates have improved to 86% and 65%, respectively), a number of neurologic complications have emerged. We performed a 14-year retrospective review of all adults and children (<18 years old) who had orthotopic cardiac transplantation at either Indiana University Hospital or James Whitcomb Riley Hospital for Children. The rates of neurologic complications involving the central and peripheral nervous systems in adults and children were assessed for differences using the chi-square test and Fisher's exact test where appropriate. A total of 191 orthotopic cardiac transplants were performed from 1986 to 2000, with follow-up available for 184, including 107 adults and 77 children. Thirty-two of 107 (30%) adults experienced a total of 47 complications, with peripheral neuropathies being the most frequent complication. Eighteen of 77 (23%) children experienced a total of 22 complications, with seizures being the most frequent complication. Other complications occurring in both groups were cerebrovascular, infectious, encephalopathies, neoplasms, and "other." Neurologic complications in children and adults after orthotopic cardiac transplantation are similar in both incidence and type. However, peripheral neuropathies tend to occur more frequently in adults than in children (P = .04), and the types of complications in the immediate post-transplant period seem to differ. (J Child Neurol 2002;17:195-199).
B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence
Routh, Jonathan C. , Ashley, Richard , Sebo, Thomas J., Lohse, Christine M. , Husmann, Douglas A. , Kramer, Stephen A., Kwon, Eugene D., Routh, Jonathan C

Mayo Clinic

Journal of Urology | March 21, 2008 | Volume: 179 | Issue: 5 | Pages: 1954-1960

10.1016/j.juro.2008.01.056 | PMID 18355839 Get It